Amerikanische Gesellschaft für Hirudotherapie

Hand-Arm Vibration Syndrome (Investigational Adjunct)

Investigational adjunct for vascular and neurosensory components of hand-arm vibration syndrome; cessation of vibration exposure, smoking cessation, calcium channel blockers for vascular component, and gabapentinoids for neurosensory pain remain evidence-based.

Tier C — InvestigationalInvestigativLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Patienten-Zusammenfassung

Ist dies FDA-zugelassen fuer diese Anwendung?
Not FDA-cleared for hand-arm vibration syndrome. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational with no controlled-trial support.
Welche Evidenz existiert?
Tier C (investigational). No controlled trials exist for HAVS. Stockholm Workshop staging guides severity. The single most important intervention is removal from vibration exposure; without that, no other therapy can halt progression. Smoking cessation, cold avoidance, calcium channel blockers (typically nifedipine) for vascular attacks, and gabapentinoids or low-dose tricyclics for neurosensory pain are the evidence-based pharmacologic approaches. Established sensorineural damage at stage 2 or higher is largely irreversible.
Hauptrisiken
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Bruising and tenderness for 5 to 10 days
  • Triggering of a Raynaud-type attack at or near the bite site
  • Worsening of distal ischemia if a practitioner places a leech too distally (the digits and ischemic acral tissue are absolutely off-limits)
  • Local skin infection or Aeromonas infection
  • Allergic reaction to leech saliva
  • Delay of vibration-exposure cessation and standard pharmacotherapy
Wer dies nicht in Betracht ziehen sollte
  • Anyone still working with vibrating tools without exposure cessation
  • Patients with digital ulceration, gangrene, or severe ischemia
  • Patients on anticoagulants or with severe anemia
  • Patients whose symptoms are better explained by carpal tunnel syndrome or cervical radiculopathy (these must be excluded first)
  • Smokers who have not addressed tobacco use (compounds vasospasm)
  • Patients whose Raynaud attacks are uncontrolled on nifedipine and need rheumatology referral
Was Sie Ihren Kliniker fragen sollten
  • What is my Stockholm Workshop stage, and is the diagnosis confirmed by sensorineural and vascular testing?
  • Have I stopped vibration exposure, and is occupational change feasible?
  • Am I on nifedipine and have other vasoactive options been considered?
  • Have carpal tunnel and cervical radiculopathy been excluded?
  • Where exactly will the leech be placed — confirm it is on warm proximal forearm, not on digits?
  • What is the realistic expected benefit, given that established sensorineural damage is usually irreversible?
Wann dringende medizinische Versorgung suchen
  • A finger turning persistently black, purple, or non-blanching white
  • New ulceration or gangrene of any digit
  • Spreading redness, warmth, pus, or red streaks around a bite site
  • Fever above 38.0 C / 100.4 F
  • Bleeding from a bite site lasting more than 24 hours
  • Rapidly progressive numbness or weakness in the arm

Was dies NICHT bedeutet

  • It does not substitute for removal from vibration exposure, which is the single most important intervention.
  • Leeches are never placed on the digits themselves or on any ischemic acral tissue.
  • It does not reverse established sensorineural damage, which is largely irreversible at stage 2 or higher.
  • Concomitant carpal tunnel syndrome or cervical radiculopathy must be excluded as alternative or additional cause.

Clinical Profile

Category
vascular
ICD-10
T75.21XA, I73.00, I73.01
Safety tier
medium

Evidence Summary

Hand-arm vibration syndrome (HAVS) results from chronic occupational exposure to vibrating tools (chainsaws, grinders, jackhammers), producing episodic digital ischemia (vibration-induced Raynaud phenomenon), sensorineural deficits, and musculoskeletal pain. Stockholm Workshop classification stages severity. Evidence-based management is removal from vibration exposure (essential), smoking cessation, cold avoidance, calcium channel blockers (nifedipine) for vascular attacks, and gabapentinoids or low-dose tricyclics for neurosensory pain. There is no curative therapy; progression depends primarily on continued exposure. No published controlled trials of hirudotherapy exist for HAVS. Mechanistic rationale of microcirculatory improvement is intuitive but unsupported by clinical evidence.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Active deep vein thrombosis (acute phase <2 weeks)
  • Critical limb ischemia (ABI <0.4)
  • Continued vibration exposure (cessation is essential)
  • Digital ulceration or gangrene
  • Placement on digits or ischemic acral tissue (absolute)
  • Severe sensorineural deficit suggesting alternate diagnosis (carpal tunnel, cervical radiculopathy)

Related Conditions

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.

Hand-Arm Vibration Syndrome (Investigational Adjunct) — Hirudotherapy Evidence | ASH